Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Self-Acupressure and Social Jet Lag in Female Health Sciences Students

NCT07410936 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-04-24
Last updated
2026-08-24

Condition(s) studied

Social Jet LagSleep DisturbanceSleep QualityCircadian Rhythm Disruption

Investigational drug(s) / intervention(s)

Self-Acupressure InterventionSham Self-Acupressure

Self-Acupressure Intervention: Participants receive structured training in self-administered acupressure at predefined acupoints (HT7, SP6, and Yintang). Training is provided face-to-face at baseline. Participants are instructed to apply acupressure daily at home using moderate, comfortable, non-painful pressure. Each session is performed according to the study protocol for a total duration of 12 weeks.

Sham Self-Acupressure: Participants receive structured training in sham self-acupressure matched to the experimental intervention in frequency, session duration, and pressure. Sham acupressure is applied daily at non-acupoint locations that are not recognized as therapeutic acupressure points, using moderate, comfortable, non-painful pressure, for a total duration of 12 weeks.

Study summary

This randomized, sham-controlled trial aims to evaluate the effects of self-administered acupressure on social jet lag, sleep patterns, and sleep quality in female health sciences students. Participants will be randomly assigned to either a self-acupressure intervention group or a sham self-acupressure control group. The intervention will be performed daily for 12 weeks. Outcomes will be assessed at baseline and at the end of the intervention period, with the primary outcome being the change in social jet lag. Secondary outcomes include changes in sleep quality, daytime sleepiness, and participant blinding assessment.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
25 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Female undergraduate students enrolled in midwifery or medical programs * Age 18 to 25 years * Regular academic schedule (work/school days and free days identifiable) * Willingness to participate and provide written informed consent * Ability to comply with daily self-acupressure practice for 12 weeks * Ability to complete sleep questionnaires and sleep diary Exclusion Criteria: * Current diagnosis of a sleep disorder requiring medical treatment (e.g., obstructive sleep apnea, narcolepsy) * Use of medications known to significantly affect sleep or circadian rhythms (e.g., hypnotics, stimulants) * Shift work or night work during the study period * Transmeridian travel (≥2 time zones) within the past 4 weeks or planned during the study period * Chronic medical or psychiatric condition that may significantly affect sleep * Current pregnancy

Primary outcome measure(s)

  • Change in Social Jet Lag (ΔSJL) — Baseline (T0) and Week 12 (end of 3-month follow-up); primary analysis uses change from baseline to Week 12 (T12 - T0)
    Change in social jet lag (hours), calculated as the absolute difference between mid-sleep time on free days (MSF) and mid-sleep time on work/school days (MSW), derived from a Munich Chronotype Questionnaire (MCTQ)-based assessment and a 14-day sleep diary. Social jet lag values range from 0 hours upward, with higher values indicating greater circadian misalignment. The primary outcome is defined as the change in social jet lag from baseline to Week 12 (Week 12 - baseline).

Trial sites (1)

FacilityCityRegionStatus
Niğde Ömer Halisdemir University Hospital Niğde Merkez Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07410936 on ClinicalTrials.gov ↗ ← All trials in Turkey